India · Delayed Price · Currency is INR Aarey Drugs & Pharmaceuticals Company Description
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.
The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil.
It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline.
In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals.
It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1990 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 132 |
| CEO | Mihir Ghatalia |
Contact Details
Address: 107, Sahakar Bhavan Mumbai, 400009 India | |
| Phone | 91 22 6287 2900 |
| Website | aareydrugs.com |
Stock Details
| Ticker Symbol | AAREYDRUGS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE198H01019 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mihir Rajesh Ghatalia B.E | Chairman and MD |
| Nimit Rajesh Ghatalia | Executive Director |
| Mira Mihir Ghatalia | Chief Financial Officer |
| A. S. Kathawala | Chief Accountant |
| Kailash Chand Jethlia | Company Secretary and Compliance Officer |